AZ files immunotherapy Imfinzi in Europe
AstraZeneca has submitted the first marketing application in Europe for its immunotherapy Imfinzi, seeking approval for the drug’s use to treat a subset of patients with lung cancer.
Read More
Tag: MedImune
- Scientists uncover new disease-driving mechanism to treat atheroschlerosis
- Study shows cholesterol-lowering drug reduces diabetic retinopathy risk
- UK dementia organisations publish new manifesto ahead of general election
- Europe contributes over €750m to African Vaccines Manufacturing Accelerator
- KCL’s mini liver model promises more effective drug testing method
